New ESPAD results: teenage drinking and smoking down, but concerns over risky cannabis use and new addictive behaviours
Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there are concerns over potentially risky cannabis use and the challenges posed by new addictive behaviours.
Registration opens for European Drugs Winter and Summer Schools 2021
The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS) (1)(2).
EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the eastern ENP region
The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new EMCDDA report: Impact of
COVID-19 disruption and a strong drug market bring new threats to health and security in Europe
High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020: Trends and Developments (1).
Facts and myths about overdose and take-home naloxone — EMCDDA publishes new resources
Over the past five years, more than 40 000 people have died of a drug-related overdose in the European Union and the UK; around 80% of these being linked to the use of heroin or other opioids. Yet, with effective intervention, they could have been prevented.
World Hepatitis Day: EMCDDA showcases hepatitis questionnaire for drug service staff to refresh knowledge and identify training needs
Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes.
Stronger together: EU agencies join forces to respond to COVID-19
Since the start of the COVID-19 pandemic, the nine JHA agencies (CEPOL, EASO, EIGE, EMCDDA, eu-LISA, Eurojust, Europol, FRA and Frontex) have been supporting the EU Member States and institutions in meeting the unprecedented challenges resulting from the outbreak of the virus in both the short an
EMCDDA welcomes external partners to virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe
The EMCDDA will be joined by a range of its external partners today in a virtual event following on from International day against drug abuse and illicit trafficking (26 June).
EMCDDA and Europol join EU institutions in dialogue on the impact of COVID-19 on the world drug situation
On the occasion of International day against drug abuse and illicit trafficking, the EMCDDA and Europol are joining representatives of the EU institutions today in providing the European perspective on the impact of COVID-19 on the world drug situation.
EMCDDA Management Board renews mandate of Alexis Goosdeel
The EMCDDA Management Board took the unanimous decision today to renew the mandate of the agency’s Director, Alexis Goosdeel, for the next five years. Mr Goosdeel took up the post of EMCDDA Director on 1 January 2016 and will now hold the position until 31 December 2025.